Trial Profile
A Phase IV, Randomized, factorial assigned, Open labelled, study to evaluate the non- interference in immune response of Typhoid Vi Capsular Polysaccharide - Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) administered to children at 9 months, to measles vaccine given concomitantly
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Typhoid vaccine Vi conjugate (Primary) ; Measles virus vaccine live
- Indications Typhoid
- Focus Therapeutic Use
- Sponsors Bharat Biotech
- 29 Aug 2016 Status changed from recruiting to completed.
- 13 May 2014 New trial record